De novo membranous nephropathy associated with donor-specific alloantibody

Clinical Transplantation

Volumn 22, Issue 1, 2008, Pages 124-127

  El Kossi, Mohsen ^a   Harmer, A ^b   Goodwin, J ^b   Wagner, B ^a   Shortland, J ^a   Angel, C ^a   McKane, W ^a  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Alloantibody; Kidney transplant; Membranous nephropathy

Indexed keywords

ALLOANTIBODY; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CANDESARTAN; CYCLOSPORIN; HLA DQ ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE CONTROL; DISEASE SEVERITY; HISTOPATHOLOGY; HLA MATCHING; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY FUNCTION TEST; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; MEMBRANOUS GLOMERULONEPHRITIS; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; REMISSION; SEROLOGY;

ADULT; FANCONI SYNDROME; GLOMERULONEPHRITIS, MEMBRANOUS; HLA-DQ ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; PROTEINURIA;

EID: 38549170994     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00741.x     Document Type: Article

References (15)

1. Schwarz A, Krause PH, Offermann G et al. Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation. Transplantation 1994: 58: 650.
2. Pirson Y, Ghysen J, Cosyns JP et al. Aetiology and prognosis of de novo graft membranous nephropathy. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985: 21: 672.
3. T erasaki PI. Humoral theory of transplantation. Am J Transplant 2003: 3: 665.
4. Piazza A, Poggi E, Borrelli L et al. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Transplantation 2001: 71: 1106.
5. Sumitran-Holgersson S. HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant 2001: 16: 897.
6. Hourmant M, Cesbron-Gautier A, Terasaki PI et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005: 16: 2804.
7. Yakupoglu U, Baranowska-Daca E, Rosen D et al. Post-transplant nephrotic syndrome: A comprehensive clinicopathologic study. Kidney Int 2004: 65: 2360.
8. Poduval RD, Josephson MA, Javaid B. Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. Semin Nephrol 2003: 23: 392.
9. Couser W. Recurrent glomerulonephritis in the renal allograft: An update of selected areas. Exp Clin Transplant 2005: 3: 283.
10. Monga G, Mazzucco G, Basolo B et al. Membranous glomerulonephritis (MGN) in transplanted kidneys: Morphologic investigation on 256 renal allografts. Mod Pathol 1993: 6: 249.
11. Debiec H, Guigonis V, Mougenot B et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002: 346: 2053.
12. Baudeau C, Delarue F, He CJ et al. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon. Exp Nephrol 1994: 2: 306.
13. Coers W, Brouwer E, Vos JT et al. Podocyte expression of MHC class I and II and intercellular adhesion molecule-1 (ICAM-1) in experimental pauci-immune crescentic glomerulonephritis. Clin Exp Immunol 1994: 98: 279.
14. Lichter-Konecki U, Broman KW, Blau EB et al. Genetic and physical mapping of the locus for autosomal dominant renal Fanconi syndrome, on chromosome 15q15.3. Am J Hum Genet 2001: 68: 264.
15. Joosten SA, Sijpkens YW, van Ham V et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 2005: 5: 383.